[go: up one dir, main page]

MX2021003369A - Lágrima ocular triple. - Google Patents

Lágrima ocular triple.

Info

Publication number
MX2021003369A
MX2021003369A MX2021003369A MX2021003369A MX2021003369A MX 2021003369 A MX2021003369 A MX 2021003369A MX 2021003369 A MX2021003369 A MX 2021003369A MX 2021003369 A MX2021003369 A MX 2021003369A MX 2021003369 A MX2021003369 A MX 2021003369A
Authority
MX
Mexico
Prior art keywords
triple
ocular tear
ocular
tear
xerophthalmia
Prior art date
Application number
MX2021003369A
Other languages
English (en)
Inventor
Villegas Ana Celcilia González
Mendoza Luis Alberto Herrera
Hernández Jesus Rivera
Original Assignee
Laboratorios Grin S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Grin S A De C V filed Critical Laboratorios Grin S A De C V
Priority to MX2021003369A priority Critical patent/MX2021003369A/es
Priority to PCT/IB2022/052617 priority patent/WO2022201032A1/en
Publication of MX2021003369A publication Critical patent/MX2021003369A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se refiere a una composición oftálmica que se puede utilizar en el tratamiento de la xeroftalmia y que proporciona 3 tipos de componentes que contienen la lágrima natural: componente lipídico, componente acuoso y componente mucoide.
MX2021003369A 2021-03-22 2021-03-22 Lágrima ocular triple. MX2021003369A (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MX2021003369A MX2021003369A (es) 2021-03-22 2021-03-22 Lágrima ocular triple.
PCT/IB2022/052617 WO2022201032A1 (en) 2021-03-22 2022-03-22 Ophthalmic triple tear

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2021003369A MX2021003369A (es) 2021-03-22 2021-03-22 Lágrima ocular triple.

Publications (1)

Publication Number Publication Date
MX2021003369A true MX2021003369A (es) 2022-09-23

Family

ID=83396402

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021003369A MX2021003369A (es) 2021-03-22 2021-03-22 Lágrima ocular triple.

Country Status (2)

Country Link
MX (1) MX2021003369A (es)
WO (1) WO2022201032A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1358883B8 (en) * 2002-04-30 2007-10-03 Sifi S.p.A Re-epithelializing pharmaceutical compositions containing xanthan gum
US20060251685A1 (en) * 2003-03-18 2006-11-09 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with Omega-3 fatty acids for alleviating dry eye
IT1393419B1 (it) * 2009-03-19 2012-04-20 Medivis S R L Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6.
US9480645B2 (en) * 2009-06-02 2016-11-01 Abbott Medical Optics Inc. Omega-3 oil containing ophthalmic emulsions
KR101492447B1 (ko) * 2013-05-20 2015-02-23 주식회사태준제약 사이클로스포린을 함유하는 나노에멀젼 점안 조성물 및 그의 제조 방법

Also Published As

Publication number Publication date
WO2022201032A1 (en) 2022-09-29

Similar Documents

Publication Publication Date Title
PH12022550438A1 (en) N4-hydroxycytidine and derivatives and anti-viral uses related thereto
MX2020010078A (es) Composicion farmaceutica que comprenden timolol.
MX2011013060A (es) Formulaciones oftalmicas, metodos de preparacion y metodos para utilizarlas.
MY159463A (en) Method and composition for treating ocular hypertension and glaucoma
MX2019003364A (es) Composiciones oftalmicas que comprenden ciclosporina.
MX2009012645A (es) Formulaciones y metodos para tratar el ojo seco.
MX2023003124A (es) Composiciones farmaceuticas oftalmicas y usos que se relacionan a las mismas.
BR112013017875A2 (pt) introdução corneana de agentes de ligação cruzada por iontoforese para o tratamento de ceratocone e composições oftálmicas relacionadas
MX2020009132A (es) Composiciones farmaceuticas que comprenden nebivolol.
EP4279063A3 (en) Ophthalmic pharmaceutical composition, preparation method therefor and application thereof
TWD223771S (zh) 護目鏡
CY1124538T1 (el) Χρηση prg4 για τη βελτιωση της δυναμικης οπτικης οξυτητας και εκτροπων υψηλοτερης ταξης
MX2023013079A (es) Metodos de generacion de celulas maduras del endotelio corneal.
MY209059A (en) Aqueous ophthalmic composition comprising diquafosol or salt thereof and polyvinylpyrrolidone
ZA202108950B (en) Oxymetazoline compositions and methods for treating ocular disorders
MX2022001069A (es) Composiciones y metodos para el tratamiento de la presbicia.
CY1111384T1 (el) Διαμορφωση των επιπεδων εκφρασης toy trpv
MX2021003369A (es) Lágrima ocular triple.
BR112022025908A2 (pt) Formulações à base de ácido hialurônico para tratamento e prevenção de hipertensão ocular e glaucoma
EP4483863A3 (en) Liquid formulations of amylin analogues
PH12022550003A1 (en) Process for the preparation of sterile ophthalmic aqueous fluticasone propionate form a nanocrystals suspensions
MX2023002946A (es) Composiciones y metodos para tratar presbicia, hipermetropia, astigmatismo, estereopsis disminuida, y sensibilidad al contraste disminuida.
WO2019090010A3 (en) Composition for treating ocular disorders such as macular degeneration, retinopathy and glaucoma
WO2018230858A3 (ko) Gly-Tβ4 (Gly-티모신β4)을 함유하는 안구건조증 치료용 약학적 조성물
WO2020091287A8 (ko) 윤기 지속형 화장료 조성물